COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Botulinum Toxin for Stomach Cancer Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01822210
Recruitment Status : Completed
First Posted : April 2, 2013
Last Update Posted : March 9, 2018
Norwegian University of Science and Technology
Information provided by (Responsible Party):
St. Olavs Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016
Publications of Results:
Andersen G, Zhao CM, Cai X, Rabben HL, Fox JG, Wang TC, Chen D, Gronbech JE. Tu1418 Intragastric Injection of Botulinum Toxin a to Treat Gastric Cancer: An Open-Label Phase II Clinical Trial. Gastroenterology 150: S1251-1252, 2016